Generic Medicine Info
Indications and Dosage
Tinea corporis, Tinea cruris, Tinea pedis
Adult: As 1% cream: Apply onto affected area and approx 1 inch of immediate surrounding areas once daily. Treatment duration: 2 weeks (tinea pedis); 1 week (tinea cruris and tinea corporis).
Child: Tinea corporis: ≥2 years Same as adult dose. Tinea pedis and tinea cruris:  ≥12 years Same as adult dose.
Special Precautions
Children. Pregnancy and lactation.
Adverse Reactions
Skin and subcutaneous tissue disorders: Cellulitis, contact dermatitis, application site reactions.
Description: Luliconazole is an imidazole antifungal. The exact mechanism of action against dermatophytes is unknown; however, it appears to inhibit the synthesis of ergosterol, a constituent of fungal cell membranes, by inhibiting the enzyme lanosterol demethylase, resulting in reduced amounts of ergosterol and a corresponding accumulation of lanosterol.
Absorption: Absorbed in small amounts following topical application.
Distribution: Plasma protein binding: >99%.
Chemical Structure

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Database. Luliconazole, CID=3003141, (accessed on May 26, 2020)

Store between 15-30°C.
MIMS Class
Topical Antifungals & Antiparasites
ATC Classification
D01AC18 - luliconazole ; Belongs to the class of imidazole and triazole derivatives. Used in the topical treatment of fungal infection.
Anon. Luliconazole. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 06/05/2020.

Buckingham R (ed). Luliconazole. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 06/05/2020.

Luliconazole Cream (Oceanside Pharmaceuticals). DailyMed. Source: U.S. National Library of Medicine. Accessed 06/05/2020.

Luzu Cream (Bausch Health US, LLC). DailyMed. Source: U.S. National Library of Medicine. Accessed 06/05/2020.

Luzu Cream, 1% for Topical Use (Valeant Pharmaceuticals North America LLC). U.S. FDA. Accessed 06/05/2020.

Disclaimer: This information is independently developed by MIMS based on Luliconazole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in